Details for Patent: 8,334,281
✉ Email this page to a colleague
Which drugs does patent 8,334,281 protect, and when does it expire?
Patent 8,334,281 protects GIMOTI and is included in one NDA.
This patent has ten patent family members in seven countries.
Summary for Patent: 8,334,281
| Title: | Nasal formulations of metoclopramide |
| Abstract: | Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with metoclopramide, comprising administering the nasal solutions to patients in need thereof. |
| Inventor(s): | D'Onofrio; Matthew J. (San Diego, CA), Gonyer; David A. (Cardiff, CA), Shah; Shirish A. (Phoenix, AZ), Madden; Stuart J. (Ellicott City, MD) |
| Assignee: | Evoke Pharma, Inc. (San Diego, CA) |
| Application Number: | 12/645,108 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,334,281 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Compound; |
Drugs Protected by US Patent 8,334,281
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Evoke Pharma Inc | GIMOTI | metoclopramide hydrochloride | SPRAY, METERED;NASAL | 209388-001 | Jun 19, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | NASAL ADMINISTRATION OF METOCLOPRAMIDE FOR TREATMENT OF DIABETIC GASTROPARESIS | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,334,281
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 2780485 | ⤷ Sign Up | |||
| Canada | 2984736 | ⤷ Sign Up | |||
| Canada | 3155873 | ⤷ Sign Up | |||
| Canada | 3224872 | ⤷ Sign Up | |||
| Denmark | 2376075 | ⤷ Sign Up | |||
| European Patent Office | 2376075 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
